Trial of L-Citrulline and Tadalafil for Erectile Dysfunction Shows Potential Combination Benefits
A randomized trial is comparing L-citrulline, tadalafil, and their combination in men with mild to moderate erectile dysfunction.
Phase III
Urology / Erectile Dysfunction
Status
Active
Sponsor
L-Citrulline
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing trial of L-Citrulline and Tadalafil for erectile dysfunction could redefine treatment protocols if the combination therapy proves more effective. This may lead to shifts in market dynamics and competitive positioning within the erectile dysfunction therapeutic area.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor the trial results, particularly the primary outcome at 12 weeks, and any reported adverse events.
Related companies & assets
Companies
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.